elagolix 200 MG Oral Tablet

RxCUI: 2049860
RxNorm name: elagolix 200 MG Oral Tablet
Display name: elagolix 200 MG Oral Tablet
Full name: elagolix 200 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Orilissa	ELAGOLIX	AbbVie Inc.	a86757b3-09c5-fd3b-1223-244e94f50a66	2025-12-19	Warnings, Adverse reactions	Exact identifier rxcui: 2049860

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
a86757b3-09c5-fd3b-1223-244e94f50a66	elagolix 200 MG Oral Tablet	PSN	111	These highlights do not include all the information needed to use ORILISSA safely and effectively. See full prescribing information for ORILISSA. ORILISSA ® (elagolix) tablets, for oral use Initial U.S. Approval: 2018	20251219
a86757b3-09c5-fd3b-1223-244e94f50a66	elagolix 200 MG (as egalolix sodium 207 MG) Oral Tablet	SY	111	These highlights do not include all the information needed to use ORILISSA safely and effectively. See full prescribing information for ORILISSA. ORILISSA ® (elagolix) tablets, for oral use Initial U.S. Approval: 2018	20251219
a86757b3-09c5-fd3b-1223-244e94f50a66	elagolix 200 MG Oral Tablet	SCD	111	These highlights do not include all the information needed to use ORILISSA safely and effectively. See full prescribing information for ORILISSA. ORILISSA ® (elagolix) tablets, for oral use Initial U.S. Approval: 2018	20251219